EPO and Nephropathy: In fact, Singh et al. reported that both erythropoietin and 1,25(OH)2D levels were lower in diabetic patients without overt nephropathy than in control subjects, although their relations with conventional clinical markers for renal tubulointerstitial injury like urinary NAG were not strong [17].